Screener
Castle Biosciences CSTL Gross Profit
Discontinued — last reported Q1 '26
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
FAQ
- What is Castle Biosciences's gross profit?
- Castle Biosciences (CSTL) reported gross profit of $63.15M in Q1 2026.
- How has Castle Biosciences's gross profit changed year-over-year?
- Castle Biosciences's gross profit decreased by 11.8% year-over-year, from $71.61M to $63.15M.
- What is the long-term trend for Castle Biosciences's gross profit?
- Over 4 years (2021 to 2025), Castle Biosciences's gross profit has grown at a 36.7% compound annual growth rate (CAGR), from $78.26M to $273.2M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Castle Biosciences's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude